血清miRNA let-7a对喉癌的诊断价值及对喉癌细胞增殖与凋亡的影响
该研究纳入50例喉癌患者和50名健康体检者,用qRT-PCR检测血清及组织let-7a表达,并将let-7a mimics转染喉癌Hep-2细胞。结果显示喉癌患者血清let-7a显著下调,与淋巴转移相关,let-7a可抑制Hep-2细胞增殖并促进凋亡,ROC曲线下面积为0.859。
要点
- 喉癌患者血清let-7a相对表达量(0.380±0.113)显著低于健康人(0.931±0.094)。
- let-7a mimics转染Hep-2细胞后增殖受抑、凋亡率升高(均P<0.01)。
- 血清let-7a诊断喉癌AUC为0.859,最佳临界值0.557,灵敏度0.794,特异度0.727。
核心结论
- let-7a可抑制喉癌Hep-2细胞增殖并促进凋亡,喉癌患者血清let-7a下调且与淋巴转移有关,有助于早期诊断与术后监测,但需进一步研究。
研究设计与样本
- 选择湖南省人民医院2016年1月至2018年4月经病理确诊的喉癌患者50例及健康体检者50名,检测喉癌组织、癌旁组织和血清let-7a表达。
- 合成let-7a mimics并采用阳离子脂质体法瞬时转染喉癌Hep-2细胞,用流式细胞术和MTT法检测凋亡与增殖。
- 计量资料用t检验或方差分析,计数资料用χ²检验及Fisher确切概率法,ROC曲线分析诊断价值。
主要发现
- 健康人血清let-7a相对表达量(0.931±0.094)显著高于喉癌患者(0.380±0.113),t=26.507,P<0.01。
- 喉癌患者术前与术后血清let-7a相对表达量分别为(0.380±0.113)和(0.493±0.164),差异有统计学意义(t=3.848,P<0.01)。
- 血清let-7a相对表达量与淋巴转移有关(t=2.946,P<0.01)。
- let-7a在喉癌组织中的相对表达量与血清中相对表达量呈正相关(r=0.466,P=0.003)。
- 转染let-7a mimics后Hep-2细胞let-7a表达上升、增殖受抑、凋亡率升高(均P<0.01)。
关键数值与推荐
- ROC曲线分析以0.557为let-7a相对表达量最佳临界值诊断早期喉癌(Ⅰ-Ⅱ期),灵敏度0.794,特异度0.727,AUC 0.859,95%CI 0.773~0.926。
临床怎么用
- 血清let-7a可作为喉癌早期诊断的候选生物标志物,并可辅助术后病情监测。
- let-7a低表达与淋巴转移相关,提示其或有助于风险评估。
局限性
- 原文指出需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the diagnostic value of serum miRNAlet-7a in laryngeal carcinoma and the effect of let-7a on proliferation and apoptosis of laryngeal carcinoma cells. Methods: Real-time quantitative PCR was used to determine the expression level of serum miRNAlet-7a. The miRNA let-7a mimetic was synthesized and transiently transfected into the laryngeal carcinoma Hep-2 cell line by cationic liposome method. The effects of up-regulation of let-7a expression on laryngeal cancer Hep-2 cells were detected by FCM and MTT assays,respectively. The association of let-7a levels with laryngeal cancer and the diagnostic value for laryngeal cancer were analyzed. Measurement data were taken by t test or analysis of variance; Counting data were analyzed by χ(2) test and Fisher exact probability method. The receiver operating characteristic curve was used to analyze the diagnostic value of let-7a for laryngeal cancer. Results: The relative expression of serum let-7a in healthy subjects was significantly higher than that in patients with laryngeal cancer (0.931±0.094) vs (0.380±0.113) (t=26.507,P<0.01). The relative expressions of serum let-7a in patients with laryngeal cancer before and after surgery were (0.380±0.113) vs(0.493±0.164),with significant difference (t=3.848,P<0.01).The relative expression of serum let-7a was related to lymph node metastasis (t=2.946, P<0.01). There was a positive correlation between the relative expression of let-7a in laryngeal carcinoma and that in serum (r=0.466,P=0.003). After transfection of let-7a mimics, Hep-2 cells showed an increased significant increase in the expression of let-7a (P<0.01), proliferation (P<0.01) and apoptosis (P<0.01). ROC curve analysis showed that the best critical value for relative expression of let-7a in the diagnosis of laryngeal carcinoma was 0.557 with a sensitivity of 0.794,a specificity of 0.727,an area under curve(AUC) of 0.859,and a 95%CI of 0.773-0.926. Conclusions: miRNA let-7a can inhibit the proliferation of laryngeal carcinoma Hep-2 cells and promote apoptosis. Serum let-7a is down-regulated in patients with laryngeal cancer and the level of let-7a is related to lymph node metastasis,which would help early diagnosis and postoperative disease monitoring of laryngeal cancer,but further research is needed. 目的: 探讨血清miRNA let-7a对喉鳞状细胞癌的诊断价值以及let-7a对喉癌细胞增殖与凋亡的影响。 方法: 选择湖南省人民医院2016年1月至2018年4月经病理确诊的喉癌患者为研究对象,实时定量PCR(qRT-PCR)测定50例患者的喉癌组织、癌旁组织和血清标本,以及50名健康体检者血清标本miRNA let-7a的表达水平。合成miRNA let-7a模拟体(let-7a mimics)并采用阳离子脂质体法瞬时转染入喉癌细胞株Hep-2内;流式细胞术、四甲基偶氮唑蓝法(MTT)分别检测let-7a表达上调后对喉癌Hep-2细胞凋亡、增殖的影响;分析血清let-7a与喉癌临床、病理指标的关联及对喉癌的诊断价值。计量资料采取t检验或方差分析;计数资料选择χ(2)检验及Fisher确切概率法;采用受试者工作特征(ROC)曲线分析let-7a对喉癌的诊断价值。 结果: 健康人和喉癌患者血清let-7a相对表达量分别为(0.931±0.094)和(0.380±0.113),差异有统计学意义(t=26.507,P<0.01);喉癌患者术前和术后血清let-7a相对表达量分别为(0.380±0.113)和(0.493±0.164),差异有统计学意义(t=3.848,P<0.01);血清let-7a相对表达量与淋巴转移有关(t=2.946, P<0.01)。let-7a在喉癌组织中的相对表达量与血清中相对表达量呈正相关(r=0.466,P=0.003)。转染let-7a mimics后Hep-2细胞中let-7a表达明显上升(P<0.01),Hep-2细胞的增殖受到抑制(P<0.01),Hep-2细胞凋亡率明显升高(P<0.01)。ROC曲线分析,以0.557为let-7a相对表达量的最佳临界值诊断早期喉癌(Ⅰ-Ⅱ期),其灵敏度为0.794,特异度为0.727,曲线下面积为0.859,95% CI为0.773~0.926。 结论: let-7a可抑制喉癌Hep-2细胞的增殖,促进其凋亡;喉癌患者血清let-7a出现下调,let-7a水平变化与淋巴转移有关,以上特点有助于喉癌的早期诊断与术后病情监测。.
引用
- Zhou E, Luo L, Ma LJ, et al. [Diagnostic value of serum miRNA let-7a for laryngeal carcinoma and effects of let-7a on proliferation and apoptosis of laryngeal carcinoma cells]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31315362. doi:10.3760/cma.j.issn.1673-0860.2019.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。